INS and cancer: Twenty-three (2.6%) target genes for miR-203a are involved in insulin signaling pathway (P = 6.72 × 10−13), 25 (2.9%) in focal adhesion (P = 2.01 × 10−11), and 31 (3.6%) in cancer-related pathways (P = 3.51 × 10−11; Table 4B).